Trevor G. Shepherd

1151 Richmond Street
London, ON, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications

ULK1's role in cancer progression and its emerging therapeutic potential.

ULK1's role in cancer progression and its emerging therapeutic potential.

Journal: Cancer biology & therapy
Published: June 17, 2026

Divergent Role of ULK1 to Balance Mitochondrial Homeostasis and Bioenergetics in Ovarian Cancer Spheroids.

Divergent Role of ULK1 to Balance Mitochondrial Homeostasis and Bioenergetics in Ovarian Cancer Spheroids.

Journal: Cancers
Published: April 17, 2026

HDAC Inhibition Induces Transient Phenotypic Inertia in Dormant OCCC Spheroids by Derepression of Cell Cycle Genes.

HDAC Inhibition Induces Transient Phenotypic Inertia in Dormant OCCC Spheroids by Derepression of Cell Cycle Genes.

Journal: Cells
Published: February 19, 2026

Isolation of extracellular vesicles from minimal volume ascites fluid using strong anion exchange beads.

Isolation of extracellular vesicles from minimal volume ascites fluid using strong anion exchange beads.

Journal: Nanoscale advances
Published: January 13, 2026

Evaluating carboplatin and PARP inhibitor combination efficacy using high-grade serous carcinoma spheroids and organoids.

Evaluating carboplatin and PARP inhibitor combination efficacy using high-grade serous carcinoma spheroids and organoids.

Journal: Cancer biology & therapy
Published: January 11, 2026

Evaluating the Therapeutic Potential of MRT68921 and Afatinib in Three-Dimensional Models of Epithelial Ovarian Cancer.

Evaluating the Therapeutic Potential of MRT68921 and Afatinib in Three-Dimensional Models of Epithelial Ovarian Cancer.

Journal: Cancers
Published: December 10, 2025

Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma.

Loss of Trp53 results in a hypoactive T cell phenotype accompanied by reduced pro-inflammatory signaling in a syngeneic orthotopic mouse model of ovarian high-grade serous carcinoma.

Journal: Oncotarget
Published: September 22, 2025

Transcriptomic Analyses of Ovarian Clear Cell Carcinoma Spheroids Reveal Distinct Proliferative Phenotypes and Therapeutic Vulnerabilities.

Transcriptomic Analyses of Ovarian Clear Cell Carcinoma Spheroids Reveal Distinct Proliferative Phenotypes and Therapeutic Vulnerabilities.

Journal: Cells
Published: April 07, 2025

CAMKKβ supports growth and viability of epithelial ovarian cancer in vitro and in vivo.

CAMKKβ supports growth and viability of epithelial ovarian cancer in vitro and in vivo.

Journal: Scientific reports
Published: March 08, 2025

ULK1 promotes metastatic progression in experimental models of epithelial ovarian cancer.

ULK1 promotes metastatic progression in experimental models of epithelial ovarian cancer.

Journal: Oncogene
Published: March 03, 2025

Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis.

Exploiting Cancer Dormancy Signaling Mechanisms in Epithelial Ovarian Cancer Through Spheroid and Organoid Analysis.

Journal: Cells
Published: December 19, 2024

LKB1 and STRADα Promote Epithelial Ovarian Cancer Spheroid Cell Invasion.

LKB1 and STRADα Promote Epithelial Ovarian Cancer Spheroid Cell Invasion.

Journal: Cancers
Published: September 09, 2024
Showing 1-12 of 59

Last Updated: 09/26/2026